🇺🇸 FDA
Patent

US 8754051

Peptide modulators of the δPKC interaction with the d subunit of F1Fo ATP synthase/ATPase and uses thereof

granted A61KA61K38/00A61K38/16

Quick answer

US patent 8754051 (Peptide modulators of the δPKC interaction with the d subunit of F1Fo ATP synthase/ATPase and uses thereof) held by Georgia Regents Research Institute, Inc. expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Georgia Regents Research Institute, Inc.
Grant date
Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61K38/16, A61P, A61P29/00